Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Neoplasms 2Vulvar Neoplasms 1Uterine Neoplasms 1Uterine Cervical Neoplasms 1Ovarian Neoplasms 1Lymphoma, Follicular 1Intellectual Disability 1Femininity 1Endometrial Neoplasms 1

Interventions

Radiotherapy 9Cisplatin 9pembrolizumab 6Methods 6fludarabine 4Papillomavirus Vaccines 4Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 4Early Intervention, Educational 4Cyclophosphamide 4durvalumab 3aldesleukin 3Vaccines, Synthetic 3Vaccines 3Radiosurgery 3Radiation 3Platinum 3Palliative Care 3Paclitaxel 3Nivolumab 3Gemcitabine 3Carboplatin 3Brachytherapy 3Bleomycin 31,2-diaminocyclohexaneplatinum II citrate 3tremelimumab 2lenvatinib 2entinostat 2aflibercept 2Trastuzumab 2Specimen Handling 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Vulvar Neoplasms × Play Therapy × Clear all
NCT05529303 2024-02-01

Prolonged Grief and Perception of Femininity in Gynecological Cancer Patients

Afyonkarahisar Health Sciences University

Phase NA Completed
80 enrolled
Gynecologic

Uterine Cervical Neoplasms, Ovarian Neoplasms, Uterine Neoplasms, Vulvar Neoplasms, Endometrial Neoplasms, Femininity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡